![Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”](https://cdn.cancerletter.com/media/2024/03/29143711/50-13-4x3-1.jpg)
![Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”](https://cdn.cancerletter.com/media/2024/03/29143711/50-13-4x3-1.jpg)
Cover Story
Conversation with The Cancer Letter
Next week, NCI will announce its plans for surviving on an austere budget given to it by Congress as fiscal year 2024 approaches the six-month mark.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- House GOP leaders propose “streamlining” NIH into 15 institutes and centers
Plan calls for slashing ARPA-H, adding oversight to infectious disease research - Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials